切换至 "中华医学电子期刊资源库"
高级检索
中华妇幼临床医学杂志(电子版)

中华妇幼临床医学杂志(电子版) ›› 2023, Vol. 19 ›› Issue (06) : 683 -688. doi: 10.3877/cma.j.issn.1673-5250.2023.06.009

论著

宫颈上皮内瘤变Ⅲ患者血清性激素水平及其与高危型人乳头瘤病毒感染的关系
蒋冉1, 邹彩艳2,†(), 桑谊荃2   
  1. 1. 徐州市中心医院检验科，徐州　221000
    2. 徐州市中心医院内分泌科，徐州　221000
  • 收稿日期:2022-11-16 修回日期:2023-11-06 出版日期:2023-12-01
  • 通信作者: 邹彩艳

Serum sex hormone levels in patients with cervical intraepithelial neoplasia grade Ⅲ and its relationship with high-risk human papillomavirus infection

Ran Jiang1, Caiyan Zou2,†(), Yiquan Sang2   

  1. 1. Department of Clinical Laboratory, Xuzhou Central Hospital, Xuzhou 221000, Jiangsu Province, China
    2. Department of Endocrinology, Xuzhou Central Hospital, Xuzhou 221000, Jiangsu Province, China
  • Received:2022-11-16 Revised:2023-11-06 Published:2023-12-01
  • Corresponding author: Caiyan Zou
  • Supported by:
    Health Plan Scientific Research Project of Xuzhou(XWRCHT20220006)
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

蒋冉, 邹彩艳, 桑谊荃. 宫颈上皮内瘤变Ⅲ患者血清性激素水平及其与高危型人乳头瘤病毒感染的关系[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(06): 683-688.

Ran Jiang, Caiyan Zou, Yiquan Sang. Serum sex hormone levels in patients with cervical intraepithelial neoplasia grade Ⅲ and its relationship with high-risk human papillomavirus infection[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(06): 683-688.

目的

探讨宫颈上皮内瘤变(CIN)Ⅲ患者血清性激素水平及其与高危型人乳头瘤病毒(HR-HPV)感染的关系。

方法

选择2019年12月至2022年2月徐州市中心医院诊治的105例CIN Ⅲ患者为研究对象，纳入观察组。选择同期在同一医院体检的107例健康受试者作为对照，纳入对照组。根据人乳头瘤病毒(HPV)检测结果，将观察组患者进一步分为HR-HPV亚组(n＝70，各型HR-HPV感染者)及非HR-HPV亚组(n＝35，各型低危型HPV或无HPV感染者)。对2组受试者或者2个亚组患者血清性激素水平，采用独立样本t检验进行统计学比较；对不同型别HR-HPV单一感染患者的血清性激素水平，采用单因素方差分析及LSD-t检验，分别进行总体及两两比较。对2组受试者HR-HPV不同型别单一、双重及总感染率，采用χ2检验进行比较。本研究遵循的程序符合徐州市中心医院医学伦理委员会要求(审批文号：201906)，所有受试者对研究知情同意，并签署临床研究知情同意书。

结果

①观察组患者血清卵泡刺激素(FSH)、促黄体激素(LH)水平，均低于对照组受试者，血清催乳素、雌二醇及孕酮水平，则均高于对照组，并且差异均有统计学意义(P<0.05)。②观察组患者HPV16、HPV18、HPV52单一感染率，HPV16＋HPV18双重感染率，以及HR-HPV总感染率，均高于对照组受试者，并且差异均有统计学意义(P<0.05)。③HR-HPV亚组患者血清FSH、LH水平分别为(1.8±0.4) mIU/mL、(1.6±0.1) mIU/mL，均低于非HR-HPV亚组的(2.4±0.5) mIU/mL、(1.9±0.3) mIU/mL；血清雌二醇浓度为(302.5±32.3) pmoL/L，则高于非HR-HPV亚组的(268.2±23.1) pmoL/L，并且差异均有统计学意义(t＝7.44、5.55、6.54，均为P<0.001)。④HPV16型感染患者血清雌二醇水平，分别高于HPV18、HPV52及HPV58型感染患者，并且差异均有统计学意义(P<0.05)；而这4个亚型HR-HPV单一感染患者血清FSH、催乳素、LH及孕酮水平比较，差异则均无统计学意义(P>0.05)。

结论

CIN Ⅲ患者血清性激素水平异常，与HR-HPV感染相关。临床可通过检测CIN Ⅲ患者血清性激素水平，监测HR-HPV感染情况，为临床制定宫颈癌防治方案提供参考。

关键词: 宫颈上皮内瘤样病变, 性腺甾类激素, 人乳头瘤病毒, 卵泡刺激素, 促黄体激素, 催乳素, 雌二醇, 孕酮, 女性
Objective

To explore serum sex hormone levels in patients with cervical intraepithelial neoplasia (CIN) grade Ⅲ and its relationship with high-risk human papillomavirus (HR-HPV) infection.

Methods

A total of 105 CIN grade Ⅲ patients treated at Xuzhou Central Hospital from December 2019 to February 2022 were selected as research objects and included in the observation group, as well as 107 healthy individuals who underwent physical examinations at the same hospital during the same period were included in the control group. According to human papillomavirus (HPV) detection results, the patients in observation group were divided into HR-HPV subgroup (n=70, various types of HR-HPV infection) and non-HR-HPV subgroup (n=35, no/various types of low-risk HPV infection). Serum sex hormone levels of two groups of subjects or two subgroups of patients were compared by independent sample t test. The serum sex hormone levels among patients with different types of HR-HPV single infection were overall and pairwise compared by one-way ANOVA and least significant difference (LSD)-t test, respectively. The single, double, and total infection rates of different types of HR-HPV between two groups of subjects were compared by chi-square test. The procedures followed in this study was approved by the Medical Ethics Committee of Xuzhou Central Hospital (Approval No. 201906), and all participants have informed consent to the study and signed the informed consent forms.

Results

① The serum levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH) in observation group were lower than those in control group, while the serum levels of prolactin, estradiol and progesterone were higher than those in control group, and the differences were statistically significant (P<0.05). ② The single infection rates of HPV16, HPV18 and HPV52, the double infection rate of HPV16+ HPV18, and the total infection rate of HR-HPV in observation group were all higher than those in control group, and the differences were statistically significant (P<0.05). ③ The serum levels of FSH and LH in HR-HPV subgroup were (1.8±0.4) mIU/mL and (1.6±0.1) mIU/mL, respectively, which were lower than those of (2.4±0.5) mIU/mL and (1.9±0.3) mIU/mL respectively in non-HR-HPV subgroup; while the serum estradiol concentration was (302.5±32.3) pmoL/L, which was higher than that of (268.2±23.1) pmoL/L in non-HR-HPV subgroup, and the differences were statistically significant (t=7.44, 5.55, 6.54, all with P<0.001). ④ The serum estradiol levels in patients with HPV16 infection were higher than those with HPV18, HPV52 and HPV58 infection, respectively, and the differences were statistically significant (P<0.05). However, there were no significant differences in serum FSH, prolactin, LH and progesterone levels among patients with single infection of these 4 types of HR-HPV (P>0.05).

Conclusions

Abnormal serum sex hormone levels in CIN grade Ⅲ patients are associated with HR-HPV infection. Clinically, we can monitor the HR-HPV infection by detecting the serum sex hormone levels of CIN grade Ⅲ patients, so as to provide reference for formulate the prevention and treatment plan for cervical cancer.

Key words: Cervical intraepithelial neoplasia, Gonadal steroid hormones, Human papillomavirus viruses, Follicle stimulating hormone, Luteinizing hormone, Prolactin, Estradiol, Progesterone, Femininity
表1 观察组与对照组受试者血清性激素水平比较(±s)
组别 例数 FSH(mIU/mL) 催乳素(mIU/L) LH(mIU/mL) 雌二醇(pmoL/L) 孕酮(nmoL/L)
观察组 105 1.9±0.5 303.2±68.4 1.7±0.5 293.6±26.4 3.3±1.2
对照组 107 4.7±1.2 204.2±51.6 6.5±2.1 176.2±25.5 1.4±0.3
t值   21.94 12.44 23.84 32.81 13.14
P值   <0.001 <0.001 <0.001 <0.001 <0.001
表2 观察组和对照组受试者HR-HPV不同亚型单一、双重及总感染率比较[例数(%)]
组别 例数 单一感染 双重感染 总感染率
HPV16 HPV18 HPV52 HPV58 HPV16＋HPV18 HPV16＋HPV52
观察组 105 28(26.7) 20(19.1) 11(10.5) 1(1.0) 6(5.7) 4(3.8) 70(66.7)
对照组 107 4(3.7) 2(1.9) 1(0.9) 0(0) 0(0) 0(0) 7(6.5)
χ2值   — — — — — — 92.38
P值   <0.001 <0.001 0.011 0.971 0.048 0.149 <0.001
表3 HR-HPV亚组和非HR-HPV亚组CIN Ⅲ患者血清性激素水平比较(±s)
组别 例数 FSH(mIU/mL) 催乳素(mIU/L) LH(mIU/mL) 雌二醇(pmoL/L) 孕酮(nmoL/L)
HR-HPV亚组 70 1.8±0.4 323.3±64.5 1.6±0.1 302.5±32.3 3.2±0.2
非HR-HPV亚组 35 2.4±0.5 293.9±52.5 1.9±0.3 268.2±23.1 3.0±0.4
t值   7.44 1.03 5.55 6.54 1.44
P值   <0.001 0.312 <0.001 <0.001 0.125
表4 不同亚型HR-HPV单一感染CIN Ⅲ患者血清性激素水平比较(±s)
HR-HPV亚型 例数 FSH(mIU/mL) 催乳素(mIU/L) LH(mIU/mL) 雌二醇(pmoL/L) 孕酮(nmoL/L)
HPV16 28 1.9±0.4 381.7±79.4 1.7±0.5 365.1±31.6 4.3±1.5
HPV18 20 2.0±0.6 374.7±85.7 2.0±0.5 341.6±25.3 4.8±1.4
HPV52 11 2.2±0.7 352.4±77.5 2.1±0.6 358.2±30.5 4.1±0.8
HPV58 1 2.8±0 343.3±0 2.3±0 334.3±0 4.2±0
F值   1.42 0.68 2.21 2.81 1.49
P值   0.246 0.775 0.068 0.023 0.437
[9]
Bartels HC, Postle J, Rogers AC, et al. Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a Meta-analysis[J]. Int J Gynecol Cancer, 2020, 30(6): 777-782. DOI: 10.1136/ijgc-2020-001197.
[10]
Nasioudis D, Albright BB, Haggerty AF, et al. Survival following minimally invasive radical hysterectomy for patients with cervical carcinoma and tumor size ≤2 cm[J]. Am J Obstet Gynecol, 2021, 224(3): 317-318.e2. DOI: 10.1016/j.ajog.2020.10.044.
[11]
Ciaffi J, van Leeuwen NM, Schoones JW, et al. Sex hormones and sex hormone-targeting therapies in systemic sclerosis: a systematic literature review[J]. Semin Arthritis Rheum, 2020, 50(1): 140-148. DOI: 10.1016/j.semarthrit.2019.07.007.
[12]
王宪伟，袁风菊，徐培，等. 高级别鳞状上皮内病变病人子宫颈切除术后人乳头瘤病毒持续感染的相关危险因素研究[J]. 安徽医药，2023, 27(12): 2412-2416. DOI: 10.3969/j.issn.1009-6469.2023.12.017.
[13]
Zhai Q, Zhang W, Zhang Z, et al. Characteristics of the cervicovaginal microenvironment in childbearing-age women with different degrees of cervical lesions and HR-HPV positivity[J]. Pol J Microbiol, 2021, 70(4): 489-500. DOI: 10.33073/pjm-2021-046.
[14]
DE Oliveira Neto CP, Brito HO, DA Costa RMG, et al. Is there a role for sex hormone receptors in head-and-neck cancer? Links with HPV infection and prognosis[J]. Anticancer Res, 2021, 41(8): 3707-3716. DOI: 10.21873/anticanres.15162.
[15]
何学森，涂常清，钟晓，等. 深圳市龙岗社区HPV筛查及感染的相关危险因素探析[J]. 中国妇幼健康研究，2020, 31(5): 573-579. DOI: 10.3969/j.issn.1673-5293.2020.05.005.
[16]
李贺同，任晶晶，王文豪，等. 雌激素及其受体协同HPV在宫颈癌肿瘤微环境中作用的研究进展[J]. 基础医学与临床，2022, 42(9): 1438-1442. DOI: 10.16352/j.issn.1001-6325.2022.09.1438.
[17]
马闻擎，李欣然，谢嘉欣，等. 免疫性早发性卵巢功能不全患者血清miR-21及外周血单核细胞Peli1的表达及意义[J]. 解放军医学杂志，2021, 46(3): 252-257. DOI: 10.11855/j.issn.0577-7402.2021.03.06.
[18]
孔艳，刘敬，程凤凤，等. Fas p53 HPV E2 HPV E6及HPV E7蛋白在不同宫颈病变组织中的表达及意义[J]. 中国妇幼保健，2021, 36(19): 4564-4567. DOI: 10.19829/j.zgfybj.issn.1001-4411.2021.19.053.
[1]
白菊萍，徐星榕，边芸. P16, P53及Ki67在子宫颈鳞状细胞癌(SCC)，宫颈上皮内瘤变(CIN)及慢性炎症中表达水平及临床意义[J]. 中国妇产科临床杂志，2022, 23(5): 474-476. DOI: 10.13390/j.issn.1672-1861.2022.05.009.
[2]
谭先杰. 郎景和院士谈子宫颈癌的防治策略[J]. 中国实用妇科与产科杂志，2021, 37(1): 1-6. DOI: 10.19538/j.fk2021010101.
[3]
Chen JY, Wang ZL, Wang ZY, et al. The risk factors of residual lesions and recurrence of the high-grade cervical intraepithelial lesions (HSIL) patients with positive-margin after conization[J]. Medicine, 2018, 97(41): e12792. DOI: 10.1097/MD.0000000000012792.
[4]
杨玉丽，胡欣，杨萍，等. 基于Tobit模型的宫颈上皮内瘤变患者健康效用值影响因素研究[J]. 中国预防医学杂志，2022, 23(10): 760-766. DOI: 10.16506/j.1009-6639.2022.10.007.
[5]
Zhang J, Cheng K, Wang Z. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a Meta-analysis[J]. Arch Gynecol Obstet, 2020, 302(6): 1329-1337. DOI: 10.1007/s00404-020-05787-w.
[6]
Son J, Park Y, Chung SH. Epithelial oestrogen receptor α is dispensable for the development of oestrogen-induced cervical neoplastic diseases[J]. J Pathol, 2018, 245(2): 147-152. DOI: 10.1002/path.5069.
[7]
林俊. 阴道镜下活检对不同级别宫颈上皮内瘤变的诊断价值及影响因素分析[J]. 中国妇幼保健，2023, 38(22): 4423-4427. DOI: 10.19829/j.zgfybj.issn.1001-4411.2023.22.032.
[8]
Falcaro M, Castañon A, Ndlela B, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study[J]. Lancet, 2021, 398(10316): 2084-2092. DOI: 10.1016/S0140-6736(21)02178-4.
[1] 石皆春, 范子玉, 邢燕. 不同筛查方法预警宫颈原位腺癌的效能[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 575-581.
[2] 张少华, 林爱齐, 张玉, 董晓云, 刘红英. HLA和IL基因多态性及其与复发性自然流产的相关性[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 251-259.
[3] 邵小丽, 林燕, 张玲玲, 韩亚琴. 超声引导下子宫肌瘤注射聚桂醇硬化术联合术后米非司酮治疗临床疗效分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 353-360.
[4] 李玉萍, 马会, 禹航. 腹腔镜下子宫动脉阻断术联合子宫肌瘤切除术治疗子宫肌瘤临床疗效[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 238-244.
[5] 魏丽坤, 张旭红, 罗营, 薛凤霞, 王颖梅, 宋学茹, 田丽娜, 张艳芳, 王艳霞, 田文艳. 卵巢子宫内膜异位囊肿发生恶变并发盆腔脓肿1例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(06): 696-702.
[6] 王璐, 樊杨. 子宫内膜癌相关生物标志物研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 511-516.
[7] 代雯荣, 赵丽娟, 李智慧. 细胞外囊泡对胚胎着床影响的研究进展[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 616-620.
[8] 冉晨曦, 沈如飞, 廖明钰, 廖倩, 周玲, 张玉玲, 隆敏. 垂体瘤孕妇的诊治与围分娩期管理[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 487-491.
[9] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[10] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[11] 李晓阳, 刘柏隆, 周祥福. 大数据及人工智能对女性盆底功能障碍性疾病的诊断及风险预测[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 549-552.
[12] 刘静, 徐爽, 缪亚军. 肺腺癌miR-3653表达与高危型人乳头瘤病毒感染及预后的关系[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 600-604.
[13] 袁捷, 乔钰琪, 李彦冬. 二甲双胍、来曲唑联合地屈孕酮治疗多囊卵巢综合征合并不孕症的效果评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 343-347.
[14] 高红琴, 陈晨, 陆瑞科, 王小雨, 张敏, 李少华, 郝梨岚, 黄新程, 关凌耀, 张韵红. 外阴阴道假丝酵母菌病对女性阴道-宫颈菌群的影响研究[J/OL]. 中华临床医师杂志(电子版), 2023, 17(06): 720-725.
[15] 周杨, 吕淑兰. 围孕期高催乳素血症的诊治与管理[J/OL]. 中华产科急救电子杂志, 2024, 13(01): 24-28.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号